Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSun Young Rha, Xiaochun Zhang, Min‐Hee Ryu et al.|The Lancet Oncology|2023Cited by 614
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancerCésar Sánchez, Matthew J. Ellis|Breast Cancer Research|2011Cited by 184